Open AccessAugmentation of Clozapine Due to Inadequate Treatment Response in Schizophrenia: Comparison of Patients with Augmented and Non-augmented Treatments
Author(s) -
Ş. Hun Şenol,
Gamze Gürcan,
Aygün Ertuğrul,
Sevilay Karahan,
A. Elif Anıl Yağcıoğlu
Publication year - 2020
Publication title -
türk psikiyatri dergisi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.218
H-Index - 28
ISSN - 1300-2163
DOI - 10.5080/u25076
Subject(s) - clozapine , schizophrenia (object oriented programming) , positive and negative syndrome scale , clinical global impression , antipsychotic , global assessment of functioning , psychiatry , quetiapine , psychopathology , atypical antipsychotic , medicine , psychology , psychosis , placebo , alternative medicine , pathology
Clozapine is considered to be a gold standard antipsychotic in treatment resistant schizophrenia. This study aims to investigate clozapine augmentation METHODS utilized in schizophrenia and compare the sociodemographic characteristics, clinical features and remission states of patients whose treatments are augmented and not.